Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Investor Update
Get the latest updates from Investor Update directly as they happen.
Follow now 367 followers
Latest posts
Last updated about 7 hours ago
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
about 7 hours ago
Group sales grew by 7%1 at constant exchange rates (CER; 2% in...
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
about 7 hours ago
Group sales grew by 7%1 at constant exchange rates (CER; 2% in...
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
2 days ago
A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight...
Reminder: Invitation to Roche’s Full Year Results 2025 Presentation
7 days ago
Roche will publish its Full Year Results of 2025 prior to the...
Invitation to Roche’s Virtual Neurology/ACTRIMS Investor Event
16 days ago
We are pleased to invite investors and analysts to participate in our...
Invitation to Roche’s Full Year Results 2025 Presentation
24 days ago
Roche will publish its Full Year Results of 2025 prior to the...
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
about 1 month ago
Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability...
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu
about 2 months ago
With this approval, Roche’s automated mass spectrometry platform now offers the industry’s...
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
about 2 months ago
Giredestrant is the only oral SERD to show superior invasive disease-free survival...
Roche launches new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark
about 2 months ago
The new PCR test aids in the diagnosis of infectious causes of...
European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
about 2 months ago
Approval based on phase II NOBILITY and phase III REGENCY studies showing...
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
about 2 months ago
Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed...